Although the present findings leave open the question as to the mechanisms of how the threshold for Aβ- and tau-induced synaptotoxicity is lowered in middle-aged rats, they help explain why ageing is a primary risk factor and support the development of interventions that target Aβ and tau in middle age prior to presentation with full-blown clinical dementia in older life. This evidence concerns the gene MAPT and dementia.